MASTER IN BIOMEDICAL ENGINEERING – BME-PARIS Molecular and Cellular Biotherapies (MCB) track

Language(s) of instruction: English (100%)

Length of study: 2 years, full-time

Partners:
Ecole Nationale Supérieure d’Arts et Métiers (ENSAM) – Institute of Technology

Course Location: Université Paris Cité, Paris, France

Degrees awarded: Master’s in Molecular and Cellular Biotherapies 

Entry Requirements:
First year (M1):

  • Hold or be completing a 3–4 year science-related Bachelor’s or Licence degree (fields such as life and health sciences, engineering, chemistry, physics, mechanics, mathematics, computer science, and other health-related fields).
  • Be a physiotherapist or 4th-year physiotherapy student

Second year (M2):

  • Hold or be completing a Master 1 (240 ECTS), full Master’s, or be in the 3rd year of an engineering school
  • Be in the 2nd year of a partner engineering school (e.g. Arts et Métiers, Mines ParisTech) for a double degree
  • Be a resident or graduate in medicine, pharmacy, or dentistry (MD, Pharm.D, DDS, DMD)
  • Physiotherapists: complete – only with additional research training

 

Language pre-requisites: English – C1 (certified: TOEIC, TOEFL, etc.)

Course overview

The BioMedical Engineering (BME-Paris) Master provides a 2-year education program in the field of bioengineering, at the crossroad of biomedical and engineering sciences. The common M1 (year 1) program is designed to strengthen and broaden students’ skills in engineering, digital sciences, and biomedical disciplines, addressing contemporary health challenges. Year 1 provides essential fundamental and practical knowledge, equipping students with an interdisciplinary background before they can choose among 4 specialized tracks in the second year (M2).

The M2 BME-Paris Molecular & Cellular Biotherapies (MCB) track offers in-depth training in cell and gene therapies, tissue engineering, and regenerative medicine. Combining lectures, lab work, and case studies, it covers key topics like stem cell biology, immunology, and bioengineering. Students also gain insight into clinical applications and regulatory frameworks, preparing them for careers in research, biotech, and the biopharmaceutical industry. The MCB track positions graduates at the forefront of advanced therapeutic innovations.

During the M1, students pursue a compulsory 2-4 month work placement. During the M2, they pursue a compulsory 5-month work placement in an academic, hospital or industrial research laboratory.

Skills and competencies developed

• Interdisciplinary foundation in engineering, biomedical, and digital sciences
• Quantitative and ethical scientific research skills
• Project design, data analysis, and use of advanced tools
• Knowledge of cell/gene therapies, stem cells, and immunology
• Expertise in gene transfer, tissue engineering, and bioengineering
• Understanding of clinical applications and regulatory frameworks
• Ability to translate research into clinical and industrial settings
• Career readiness for academia, biopharma, and biotech in advanced therapies

Contact

Pedagogical contacts
Track coordinators
Ms. Salima HACEIN-BEY
salima.hacein-bey @ aphp.fr
Mr. Romain FONTAINE
Romain.fontaine@inserm.fr
Ms. Stéphanie BESSOLES
stephanie.bessoles @ u-paris.fr
Administrative contact
Ms. Isabelle GUENERIE
isabelle.guenerie@u-paris.fr

 

Website
Website